Colazal (KOL-a-zal), a new drug for ulcerative colitis

December 2000

Salix Pharmaceuticals is now marketing Colazal (KOL-a-zal), a new drug for ulcerative colitis.

Colazal (balsalazide) is broken down by bacteria in the colon to release mesalamine and an inert compound.

Asacol and Pentasa are delayed-release mesalamine products that rely on the emptying rate of the stomach and pH of the GI tract. Some is released before reaching the colon and is absorbed systemically.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

fibromyalgia
take phenylpropanolamine off the market
Diabetes more focus on lowering POSTPRANDIAL glucose
Cardiology high potassium foods may reduce the risk of high blood pressure and stroke
Cardiology guidelines for potassium replacement
Cardiology new low-molecular-weight heparin called Innohep
Gastroenterology Colazal (KOL-a-zal), a new drug for ulcerative colitis
Infectious Diseases Relenza and Tamiflu to PREVENT flu
Infectious Diseases shortage of ADULT tetanus-diphtheria vaccine
DHEA (dehydroepiandrosterone) is useful for treating lupus
Women's Health using testosterone for women
Women's Health Menopause Educator Certificate
You'll see two new meds for HIV
Multiple Sclerosis multiple sclerosis patients using Novantrone
Dispensing Centralized facilities and unit-of-use packaging

Colazal (KOL-a-zal), a new drug for ulcerative colitis

Practical advice for a better career, with unlimited access to CE

Table of Contents